(Reuters) - Swiss pharmaceutical supplier Lonza Group AG (LONN.S) on Thursday announced a deal to buy Capsugel, a U.S. maker of capsules and other drug delivery systems, from KKR & Co LP (KKR.N) for ...
The Swiss pharmaceutical services firm Lonza has agreed to acquire Capsugel, a specialist in oral drug delivery technologies, from the private equity firm KKR for $5.5 billion. The deal follows others ...
Sep 23, 2008 (CompanyNewsGroup via COMTEX) -- NicOx S.A. (Euronext Paris: COX) today announced it has signed an exclusive agreement with Capsugel, the leading producer of two-piece capsules, for the ...
Morristown, N.J., Oct. 22, 2013 – Capsugel is launching an innovative capsule design to improve adherence to treatment regimens for patients with difficulties swallowing. These patients include babies ...
Powerful Alliance of Industry Leaders Helps Protect Pharmaceutical Supply Chain February 22, 2010 - Skokie, Illinois: NanoGuardianTM, a division of NanoInk® that delivers brand protection solutions to ...
Innovative injection molding technology produces a wide range of dosage forms for new methods of oral drug delivery February 9, 2011 - Madison, NJ: Capsugel, the world's leading hard capsule ...
Inc. said Monday it will sell its Capsugel capsule-making business to private equity firm Kohlberg Kravis Robert & Co. for $2.38 billion in cash. , which is the world's biggest drugmaker, and ...
The Swiss pharmaceutical services firm Lonza has agreed to acquire Capsugel, a specialist in oral drug delivery technologies, from the private equity firm KKR for $5.5 billion. The deal follows others ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results